Why Penumbra (PEN) Stock Is Trading Up Today
Shares of medical device company Penumbra (NYSE:PEN) jumped 13.6% in the afternoon session after the company reported impressive fourth-quarter 2024 results, which blew past analysts' constant currency revenue, EBITDA, and earnings expectations. Sales grew by 10.8% compared to the previous year due to strong performance in its U.S. thrombectomy business, which surged 27.3%. This strength helped offset a 16.5% decline in international sales, largely due to weaker performance in China. However, de